Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Leap Therapeutics Inc (LPTX)

Leap Therapeutics Inc (LPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 84,952
  • Shares Outstanding, K 41,440
  • Annual Sales, $ 0 K
  • Annual Income, $ -67,560 K
  • EBIT $ -67 M
  • EBITDA $ -67 M
  • 60-Month Beta -0.06
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.86
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.58
  • Most Recent Earnings $-0.40 on 08/14/25
  • Next Earnings Date 11/12/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.20
  • Number of Estimates 1
  • High Estimate -0.20
  • Low Estimate -0.20
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +45.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3900 +421.63%
on 11/06/25
2.5400 -19.29%
on 11/12/25
+1.4100 (+221.07%)
since 10/10/25
3-Month
0.2300 +782.48%
on 08/14/25
2.5400 -19.29%
on 11/12/25
+1.7300 (+533.89%)
since 08/12/25
52-Week
0.2200 +822.18%
on 04/04/25
3.6100 -43.21%
on 11/13/24
-1.2000 (-36.92%)
since 11/12/24

Most Recent Stories

More News
Cypherpunk Stock Soars on Zcash Rebrand. Should You Buy the Crypto Penny Stock Here?

Cypherpunk Technologies soars as it transforms from a biotech firm to a Zcash treasury company. But several risks warrant taking profit in CYPH stock at current levels.

CYPH : 1.1100 (-12.60%)
^ZECUSD : 341.9030 (-3.90%)
^BTCUSD : 89,539.95 (+0.38%)
LPTX : 2.0500 (+368.57%)
This Penny Stock Is Pivoting to the Zcash Crypto. Should You Buy Shares After Its November 13 Rebrand?

Leap Therapeutics stock skyrockets as the company announces a ZCash-focused crypto treasury strategy. But the strategic pivot is coupled with substantial risks that warrant caution on LPTX shares.

^ZECUSD : 341.9030 (-3.90%)
LPTX : 2.0500 (+368.57%)
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results

CAMBRIDGE, Mass. , Nov. 12, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc. (Nasdaq:LPTX), a company developing novel therapies for patients with cancer...

LPTX : 2.0500 (+368.57%)
Leap Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy

Khing Oei appointed Chairman of the Board; Will McEvoy appointed Chief Investment Officer and Member of the Board; Cypherpunk Technologies Inc. announces acquisition of 203,775.27...

CYPH : 1.1100 (-12.60%)
LPTX : 2.0500 (+368.57%)
Leap Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy

Khing Oei appointed Chairman of the Board; Will McEvoy appointed Chief Investment Officer and Member of the Board; Cypherpunk Technologies Inc. announces acquisition of 203,775.27...

CYPH : 1.1100 (-12.60%)
LPTX : 2.0500 (+368.57%)
Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025

Sirexatamab demonstrated statistically significant improvement in PFS and OS in DKK1-high population

LPTX : 2.0500 (+368.57%)
Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy

CAMBRIDGE, Mass. , Oct. 9, 2025 /PRNewswire/ -- Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has...

LPTX : 2.0500 (+368.57%)
Leap Therapeutics Announces $58.88M Private Placement

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Leap Therapeutics...

LPTX : 2.0500 (+368.57%)
Leap Therapeutics Announces $58.88 Million Private Placement in Cash Commitments Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy

CAMBRIDGE, Mass. , Oct. 6, 2025 /PRNewswire/ -- Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced $58,888,888...

LPTX : 2.0500 (+368.57%)
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion

EQNX::TICKER_START (NASDAQ:GTBP),(NASDAQ:LPTX),(NASDAQ:IOBT),(NASDAQ:CELC),(NYSE:MAIA) EQNX::TICKER_END

CELC : 105.63 (-0.23%)
GTBP : 0.6094 (-3.24%)
IOBT : 0.6967 (+2.74%)
LPTX : 2.0500 (+368.57%)
MAIA : 1.2000 (unch)

Business Summary

Leap Therapeutics, Inc. is a biopharmaceutical company. It develops novel therapeutics for the treatment of cancer. Leap Therapeutics, Inc. is based in Cambridge, United States.

See More

Key Turning Points

3rd Resistance Point 4.8200
2nd Resistance Point 3.6800
1st Resistance Point 2.8700
Last Price 2.0500
1st Support Level 0.9100
2nd Support Level N/A
3rd Support Level N/A

See More

52-Week High 3.6100
Fibonacci 61.8% 2.3200
Last Price 2.0500
Fibonacci 50% 1.9200
Fibonacci 38.2% 1.5200
52-Week Low 0.2200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar